KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palvella Therapeutics (PVLA) Current Leases (2021 - 2023)

Historic Current Leases for Palvella Therapeutics (PVLA) over the last 3 years, with Q3 2023 value amounting to $12.3 million.

  • Palvella Therapeutics' Current Leases rose 138813.56% to $12.3 million in Q3 2023 from the same period last year, while for Sep 2023 it was $12.3 million, marking a year-over-year increase of 138813.56%. This contributed to the annual value of $859000.0 for FY2022, which is 1811.25% down from last year.
  • As of Q3 2023, Palvella Therapeutics' Current Leases stood at $12.3 million, which was up 138813.56% from $910000.0 recorded in Q2 2023.
  • In the past 5 years, Palvella Therapeutics' Current Leases registered a high of $12.3 million during Q3 2023, and its lowest value of $826000.0 during Q3 2022.
  • In the last 3 years, Palvella Therapeutics' Current Leases had a median value of $900000.0 in 2023 and averaged $2.8 million.
  • In the last 5 years, Palvella Therapeutics' Current Leases tumbled by 1811.25% in 2022 and then surged by 138813.56% in 2023.
  • Palvella Therapeutics' Current Leases (Quarter) stood at $1.0 million in 2021, then fell by 18.11% to $859000.0 in 2022, then soared by 1330.97% to $12.3 million in 2023.
  • Its Current Leases was $12.3 million in Q3 2023, compared to $910000.0 in Q2 2023 and $890000.0 in Q1 2023.